|
US8168181B2
(en)
|
2006-02-13 |
2012-05-01 |
Alethia Biotherapeutics, Inc. |
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
|
|
CA2822302A1
(en)
|
2006-02-13 |
2007-08-23 |
Alethia Biotherapeutics Inc. |
Methods of impairing osteoclast differentiation
|
|
EP2132312B1
(en)
|
2007-03-27 |
2016-01-27 |
Sea Lane Biotechnologies,llc. |
Constructs and libraries comprising antibody surrogate light chain sequences
|
|
CA2761681A1
(en)
|
2009-05-13 |
2010-11-18 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to influenza viruses
|
|
DK2516469T3
(en)
|
2009-12-22 |
2016-05-02 |
Roche Glycart Ag |
ANTI-HER3 antibodies and uses thereof
|
|
WO2011136911A2
(en)
|
2010-04-09 |
2011-11-03 |
Aveo Pharmaceuticals, Inc. |
Anti-erbb3 antibodies
|
|
PL2606070T3
(pl)
|
2010-08-20 |
2017-06-30 |
Novartis Ag |
Przeciwciała dla receptora epidermalnego czynnika wzrostu 3 (her3)
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
ES2692379T3
(es)
|
2010-11-01 |
2018-12-03 |
Symphogen A/S |
Anticuerpos anti-HER3 y composiciones
|
|
ITRM20100577A1
(it)
*
|
2010-11-02 |
2012-05-03 |
Takis Srl |
Immunoterapia contro il recettore erbb-3
|
|
JP2014508782A
(ja)
|
2011-03-11 |
2014-04-10 |
メリマック ファーマシューティカルズ インコーポレーティッド |
ホルモン不応性乳癌の治療におけるｅｇｆｒファミリー受容体の阻害剤の使用
|
|
CN103429262A
(zh)
|
2011-03-15 |
2013-12-04 |
梅里麦克制药股份有限公司 |
克服对erbb途径抑制剂的抗性
|
|
HRP20170713T1
(hr)
|
2011-04-19 |
2017-07-14 |
Merrimack Pharmaceuticals, Inc. |
Bispecifično anti-igf-1r i anti-erbb3 antitijelo
|
|
EP2736928B1
(en)
*
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Sur-binding proteins against erbb3
|
|
WO2013033008A2
(en)
|
2011-08-26 |
2013-03-07 |
Merrimack Pharmaceuticals, Inc. |
Tandem fc bispecific antibodies
|
|
JP6271432B2
(ja)
|
2011-09-30 |
2018-01-31 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
抗ＥｒｂＢ３抗体およびその使用
|
|
US9273143B2
(en)
|
2011-09-30 |
2016-03-01 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody
|
|
US9828635B2
(en)
|
2011-10-06 |
2017-11-28 |
Aveo Pharmaceuticals, Inc. |
Predicting tumor response to anti-ERBB3 antibodies
|
|
MX350957B
(es)
*
|
2011-11-23 |
2017-09-27 |
Medimmune Llc |
Moleculas de union especificas para her3 y usos de las mismas.
|
|
KR20140099315A
(ko)
*
|
2011-12-05 |
2014-08-11 |
노파르티스 아게 |
Her3의 도메인 iii 및 도메인 iv에 대해 지시된 표피 성장 인자 수용체 3 (her3)에 대한 항체
|
|
EP2788382A2
(en)
*
|
2011-12-05 |
2014-10-15 |
Novartis AG |
Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3
|
|
AU2012349735B2
(en)
|
2011-12-05 |
2016-05-19 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (HER3)
|
|
WO2013096828A1
(en)
|
2011-12-22 |
2013-06-27 |
Sea Lane Biotechnologies, Llc |
Surrogate binding proteins
|
|
WO2014012165A1
(en)
|
2012-07-19 |
2014-01-23 |
Alethia Biotherapeutics Inc. |
Anti-siglec-15 antibodies
|
|
AR094403A1
(es)
|
2013-01-11 |
2015-07-29 |
Hoffmann La Roche |
Terapia de combinación de anticuerpos anti-her3
|
|
MX2015011712A
(es)
|
2013-03-06 |
2016-04-04 |
Merrimack Pharmaceuticals Inc |
Anticerpos biespecificos fc en fila anti-c-met.
|
|
EP2821071A1
(en)
|
2013-07-04 |
2015-01-07 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compounds for breast cancer treatment
|
|
WO2015048008A2
(en)
|
2013-09-24 |
2015-04-02 |
Medimmune, Llc |
Binding molecules specific for her3 and uses thereof
|
|
US10035847B2
(en)
|
2013-10-02 |
2018-07-31 |
The Rockefeller University |
Amyloid protofibril antibodies and methods of use thereof
|
|
WO2015100459A2
(en)
|
2013-12-27 |
2015-07-02 |
Merrimack Pharmaceuticals, Inc. |
Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
|
|
US10538591B2
(en)
*
|
2014-03-10 |
2020-01-21 |
The Brigham And Women's Hospital, Inc. |
Anti-fibulin-3 antibodies and uses thereof
|
|
WO2015143126A1
(en)
|
2014-03-19 |
2015-09-24 |
Mackay Memorial Hospital Of Taiwan Presbyterian Church And Mackay Memorial Social Work Foundation |
Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
|
|
SG11201607258SA
(en)
*
|
2014-04-10 |
2016-10-28 |
Obi Pharma Inc |
Antibodies, pharmaceutical compositions and uses thereof
|
|
WO2015157634A1
(en)
|
2014-04-11 |
2015-10-15 |
Kolltan Pharmaceuticals, Inc. |
Anti-erbb antibodies and methods of use thereof
|
|
CA2959775A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
|
CA2959716A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
|
KR102390359B1
(ko)
*
|
2014-09-29 |
2022-04-22 |
삼성전자주식회사 |
폴리펩타이드, 이를 포함하는 항 VEGF 항체 및 항 c-Met/항 VEGF 이중 특이 항체
|
|
CN104861068B
(zh)
*
|
2015-01-23 |
2020-11-17 |
中国人民解放军军事科学院军事医学研究院 |
一种全人源抗her3抗体及其治疗相关疾病的用途
|
|
US10184006B2
(en)
|
2015-06-04 |
2019-01-22 |
Merrimack Pharmaceuticals, Inc. |
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
|
|
CA3000531A1
(en)
*
|
2015-10-07 |
2017-04-13 |
Obi Pharma, Inc. |
Novel carbohydrate antibodies, pharmaceutical compositions and uses thereof
|
|
US20180346571A1
(en)
*
|
2015-11-17 |
2018-12-06 |
Oncomed Pharmaceuticals, Inc. |
Pd-l1-binding agents and uses thereof
|
|
HK1258375A1
(zh)
|
2015-11-24 |
2019-11-08 |
Onk Therapeutics Limited |
人源化抗-cll-1抗体
|
|
KR101746152B1
(ko)
*
|
2015-12-07 |
2017-06-13 |
주식회사 이수앱지스 |
ＥｒｂＢ3에 특이적으로 결합하는 항체 및 그의 용도
|
|
MA43416A
(fr)
|
2015-12-11 |
2018-10-17 |
Regeneron Pharma |
Méthodes pour ralentir ou empêcher la croissance de tumeurs résistantes au blocage de l'egfr et/ou d'erbb3
|
|
AU2017235450A1
(en)
|
2016-03-15 |
2018-08-16 |
Merrimack Pharmaceuticals, Inc. |
Methods for treating ER+, HER2-, HRG+ breast cancer using combination therapies comprising an anti-ErbB3 antibody
|
|
HUE058657T2
(hu)
*
|
2016-06-23 |
2022-09-28 |
Jiangsu Hengrui Medicine Co |
Lag-3 antitest, antigénkötõ fragmentuma és gyógyszerészeti alkalmazása
|
|
CN106692969B
(zh)
*
|
2016-12-08 |
2021-08-10 |
北海康成（北京）医药科技有限公司 |
抗erbb3抗体及其用途
|
|
CA3047833A1
(en)
*
|
2016-12-22 |
2018-06-28 |
Icahn School Of Medicine At Mount Sinai |
Anti-lilrb3 antibodies and methods of use thereof
|
|
KR20240074000A
(ko)
|
2017-02-28 |
2024-05-27 |
다이이찌 산쿄 가부시키가이샤 |
항 her3 항체-약물 콘주게이트 투여에 의한 egfr-tki 저항성의 비소세포 폐암의 치료 방법
|
|
JOP20180021A1
(ar)
|
2017-03-16 |
2019-01-30 |
Janssen Biotech Inc |
الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها
|
|
EP3600421A4
(en)
*
|
2017-03-23 |
2021-01-06 |
The Trustees of The University of Pennsylvania |
ANTI-C5A ANTIBODIES AND USES OF THEM
|
|
CN113683698B
(zh)
*
|
2017-06-22 |
2023-03-31 |
北海康成（北京）医药科技有限公司 |
预测食管癌对抗erbb3抗体治疗的应答的方法和试剂盒
|
|
CA3070100A1
(en)
*
|
2017-07-17 |
2019-01-24 |
Janssen Biotech, Inc. |
Antigen binding regions against fibronectin type iii domains and methods of using the same
|
|
JP2020532991A
(ja)
|
2017-09-07 |
2020-11-19 |
オーガスタ ユニバーシティ リサーチ インスティテュート，インコーポレーテッド |
プログラム細胞死タンパク質１に対する抗体
|
|
WO2019076277A1
(zh)
*
|
2017-10-17 |
2019-04-25 |
江苏恒瑞医药股份有限公司 |
抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途
|
|
TW201946654A
(zh)
|
2018-03-05 |
2019-12-16 |
比利時商健生藥品公司 |
抗ＰＨＦ－Ｔａｕ抗體及其用途
|
|
GB201804094D0
(en)
|
2018-03-14 |
2018-04-25 |
Ultrahuman Thirteen Ltd |
ERBB3 Binding agents
|
|
BR112020015999A2
(pt)
|
2018-04-06 |
2020-12-15 |
Dana-Farber Cancer Institute, Inc. |
Kir3dl3 como um receptor de hhla2, anticorpos anti-hhla2 e usos dos mesmos
|
|
WO2020059772A1
(ja)
|
2018-09-20 |
2020-03-26 |
第一三共株式会社 |
抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｈｅｒ３変異がんの治療
|
|
WO2020163646A1
(en)
*
|
2019-02-08 |
2020-08-13 |
Igm Biosciences, Inc. |
Anti-gitr antigen-binding domains and uses thereof
|
|
WO2020214957A1
(en)
*
|
2019-04-19 |
2020-10-22 |
Tcrcure Biopharma Corp. |
Anti-pd-1 antibodies and uses thereof
|
|
CN118465272B
(zh)
*
|
2019-12-04 |
2025-08-19 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
US20230075244A1
(en)
*
|
2020-02-20 |
2023-03-09 |
The Feinstein Institutes For Medical Research |
Agonist antibodies against endoglin and uses thereof
|
|
WO2021188631A1
(en)
*
|
2020-03-18 |
2021-09-23 |
Kindred Biosciences, Inc. |
Anti-il4 receptor antibodies for veterinary use
|
|
WO2022144025A1
(zh)
*
|
2021-01-04 |
2022-07-07 |
上海翰森生物医药科技有限公司 |
一种抗erbb3受体的抗体或其抗原结合片段及其医药用途
|
|
WO2023147470A2
(en)
|
2022-01-28 |
2023-08-03 |
Georgiamune Inc. |
Antibodies to programmed cell death protein 1 that are pd-1 agonists
|
|
CN114940714B
(zh)
*
|
2022-05-20 |
2023-06-16 |
湖南师范大学 |
肝癌标志物soat1单克隆抗体制备及其应用
|
|
CA3258344A1
(en)
|
2022-06-07 |
2023-12-14 |
Actinium Pharmaceuticals Inc |
CHELETARIANS AND BIFUNCTIONAL CONJUGATES
|
|
CN115109161B
(zh)
*
|
2022-06-28 |
2023-08-11 |
广东赛尔生物科技有限公司 |
含有间充质干细胞的减肥药物组合物
|
|
EP4637821A1
(en)
*
|
2022-12-23 |
2025-10-29 |
Actinium Pharmaceuticals, Inc. |
Her3 radioimmunotherapy for the treatment of solid cancers
|
|
CN118005795B
(zh)
*
|
2024-04-09 |
2024-06-28 |
天津旷博同生生物技术有限公司 |
一种抗人cd64抗体及应用
|